Related scientific articles (all)

Axillary recurrence rate in breast cancer patients with negative sentinel lymph node biopsy or containing micrometastases and without further lymphadenectomy: a monocentric review of 8 years and 481 cases.

Authors : Toussaint A, Nogaret JM, Veys I, Hertens D, Noterman D, De Neubourg F, Larsimont D, Bourgeois P
Year : 2011
Journal : Breast J
Volume : 17(4)
Pages : 337-42

Uvular and tonsillar pillar mucosal necrosis as a cause of severe sore throat after orotracheal intubation.

Authors : Salengros JC, El Founas W, Velghe Lenelle CE, Willemse E, Sosnowski M, Andry G, Digonnet A
Year : 2011
Journal : Anaesth Intensive Care
Volume : 39(4)
Pages : 772-3

Integrating biomarkers in clinical trials.

Authors : Buyse M, Michiels S, Sargent DJ, Grothey A, Matheson A, de Gramont A
Year : 2011
Journal : Expert Rev. Mol. Diagn.
Volume : 11(2)
Pages : 171-82

Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.

Authors : Martinelli F, Quinten C, Maringwa JT, Coens C, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Mendoza T, Osoba D, Reeve BB, Ringash J, Koch JS, Shi Q, Taphoorn MJ, Weis J, Bottomley A, + collaborators (among others :, Piccart-Gebhart M
Year : 2011
Journal : Expert Rev Pharmacoecon Outcomes Res
Volume : 11(5)
Pages : 587-99

Gene-expression changes over time in a tamoxifen-treated breast cancer xenograft model.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 11

Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations.

Authors : Floor S, van Staveren WC, Larsimont D, Dumont JE, Maenhaut C
Year : 2011
Journal : Oncogene
Volume : 30(46)
Pages : 4609-21

Single-access transumbilical laparoscopic appendectomy and cholecystectomy using new curved reusable instruments: a pilot feasibility study.

Authors : Dapri G, Casali L, Dumont H, Van der Goot L, Herrandou L, Pastijn E, Sosnowski M, Himpens J, Cadière GB
Year : 2011
Journal : Surg Endosc
Volume : 25(4)
Pages : 1325-32

The EORTC 10041/BIG03-04 MINDACT trial is feasible : results of the pilot phase.

Authors : Rutgers E, Piccart-Gebhart M, Bogaerts J, Delaloge S, Veer LV, Rubio IT, Viale G, Thompson AM, Passalacqua R, Nitz U, Vindevoghel A, Pierga JY, Ravdin PM, Werutsky G, Cardoso F
Year : 2011
Journal : Eur J Cancer
Volume : 47(18)
Pages : 2742-9

The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties.

Authors : Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Year : 2011
Journal : Cell. Immunol.
Volume : 270(2)
Pages : 207-16

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007.

Authors : Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G, + collaborators (among others :, Aoun M
Year : 2011
Journal : Clin. Microbiol. Infect.
Volume : 17(12)
Pages : 1859-67

CD44+ CD24-/low phenotype and resistance to trastuzumab in HER2-positive breast cancer cell lines.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 12-3

How much is residents' distress detection performance during a clinical round related to their characteristics?

Authors : Meunier J, Libert Y, Merckaert I, Delvaux N, Etienne AM, Liénard A, Marchal S, Reynaert C, Slachmuylder JL, Razavi D
Year : 2011
Journal : Patient Educ Couns
Volume : 85(2)
Pages : 180-7

Unravelling the epigenomic dimension of breast cancers.

Authors : Dedeurwaerder S, Fumagalli D, Fuks F
Year : 2011
Journal : Curr Opin Oncol
Volume : 23(6)
Pages : 559-65

Non Hodgkin's lymphomas: a major breakthrough with immunotherapy].

Authors : Firescu R, Muylle K, Roelandts M, de Wind A, Moerman C, Lemort M, Kentos A, Meuleman N, Bron D
Year : 2011
Journal : Rev Med Brux
Volume : 32(2)
Pages : 83-92

Moterhood after Breast Cancer : searching for la dolce vita. Expert Rev.

Authors : Azim HA, Peccatori FA, de Azambuja E, Piccart-Gebhart M
Year : 2011
Journal : Anticancer Res
Volume : 11(2)
Pages : 287-298

Genomic Grade Index: An important tool for assessing breast cancer tumor grade and prognosis.

Authors : Filho OM, Ignatiadis M, Sotiriou C
Year : 2011
Journal : Crit Rev Oncol Hematol
Volume : 77(1)
Pages : 20-9

Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.

Authors : Id Boufker H, Lagneaux L, Fayyad-Kazan H, Badran B, Najar M, Wiedig M, Ghanem G, Laurent G, Body JJ, Journe F
Year : 2011
Journal : Bone
Volume : 49(6)
Pages : 1219-31

Pattern of care in locally advanced breast cancer: focus on local therapy.

Authors : Sinacki M, Badzio A, Welnicka-Jaskiewicz M, Bogaerts J, Piccart-Gebhart M, Therasse P, Smith IE, Hatschek T, Jassem J
Year : 2011
Journal : Breast
Volume : 20(2)
Pages : 145-50

Prevention of febrile neutropenia in chemotherapy – treated cancer patients : Pegylated versus standard myeloid colony stimulating factors. Do we have a choice ?

Authors : Klastersky J, Awada A
Year : 2011
Journal : Crit Rev Oncol Hematol
Volume : 78(1)
Pages : 17-23

External quality assurance of circulating tumor cell enumeration using the CellSearch(®) system: a feasibility study.

Authors : Kraan J, Sleijfer S, Strijbos MH, Ignatiadis M, Peeters D, Pierga JY, Farace F, Riethdorf S, Fehm T, Zorzino L, Tibbe AG, Maestro M, Gisbert-Criado R, Denton G, de Bono JS, Dive C, Foekens JA, Gratama JW
Year : 2011
Journal : Cytometry B Clin Cytom
Volume : 80(2)
Pages : 112-8